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(Fig.  2a).  Most  of  the  oncocytic  cells  showed  positive  expres-LETTER / Gastrointestinal imaging
A spindle cell sarcoma of liver
supplied by internal mammary
artery
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Primary  sarcomas  of  the  liver  are  extremely  rare  and  con-
stitute  approximately  0.1%  of  primary  malignant  neoplasms
of  the  liver  [1].  Although  the  hepatic  artery  (HA)  is  the  main
feeding  artery  to  most  tumors  of  the  liver,  extrahepatic  col-
lateral  arteries  may  also  supply  the  tumors.  We  report  here
in  detail  a  spindle  cell  sarcoma  of  the  liver  which  was  exclu-
sively  supplied  by  the  right  internal  mammary  artery  (IMA)
rather  than  the  HA.
Case  reportA  46-year-old  man  presented  with  4-year  duration  of
intermittent  discomfort  in  the  right  upper  quadrant
of  the  abdomen.  Initial  laboratory  results  upon  presentation
Figure 1. CT ﬁndings and arterial anatomy of hepatic spindle cell sa
hepatic mass, which demonstrates minimal heterogeneous contract enha
internal mammary artery (IMA) are present on arterial phase imaging (a,
of iodized oil within the mass 1 month after the ﬁrst chemoembolization
reveals potential tumor arterial supply arising from the right IMA (white a
demonstrate predominant tumor supply from the right IMA (d) and minim
chemoembolization (TACE) session. The hepatic artery contributes to tu
angiography (f).
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2211-5684/© 2014 Éditions franc¸aises de radiologie. Published by Elseviencluded  serum  alanine  aminotransferase  132  U/L  (normal
evel  0—40  U/L),  aspartate  aminotransferase  67  U/L  (nor-
al  level  0—40  U/L),  and  cancer  antigen  125  74.49  U/mL
normal  level  <  35  U/mL).  -fetoprotein  was  normal.  Hepati-
is  B  surface  antigen  and  hepatitis  C  surface  antibody  were
egative.
Ultrasound  suggested  a  hypoechoic  mass  abutting  the
iaphragm  in  the  right  lobe  of  the  liver.  CT  images
evealed  a  heterogeneous  enhancement  mass  about  12.9  cm
n  diameter  with  visible  feeding  branches  of  the  IMA
Fig.  1a).  Reconstructed  maximum  intensity  projection  (MIP)
T  images  revealed  probable  tumor  arterial  supply  arising
rom  the  HA  and  right  IMA  (Fig.  1c).
Percutaneous  biopsy  of  the  mass  was  performed  under
ltrasound  guidance.  Histologically,  the  mass  was  predom-
nantly  comprised  of  spindle  or  oval  cells  with  abundant
osinophilic  cytoplasm  and  dotted  with  lipid-like  vacuolesrcoma. Enhanced axial CT image reveals a hypoattenuating, right
ncement on arterial phase imaging (a). Visible branches of the right
 arrow). Unenhanced axial CT image shows scattered accumulation
 via the right IMA (b). Maximum intensity projection CT image (c)
rrow head) and hepatic artery (white arrow). Selective angiograms
al hepatic artery tumor supply (e) at initial transcatheter arterial
mor arterial supply at the sixth TACE session by selective contrast
ion  of  CD117  (c-kit)  (Fig.  2b),  vimentin  (Fig.  2c)  and  Ki-67
Fig.  2d),  but  negative  expression  of  AE1/AE3,  CK8,  Actin,
MA,  HMB45,  S-100  and  Lysozyme.  Collectively,  the  tumor
r Masson SAS. All rights reserved.
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Figure 2. Microscopic and immunohistochemical ﬁndings of spindle cell sarcoma. H&E stained sections reveals that the mass is mainly
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[ade up of spindle or oval cells with abundant eosinophilic cytopl
b), vimentin (c) and Ki-67 (d) (original magniﬁcation: ×200).
eached  a  pathological  diagnosis  of  mesenchymal  spindle
ell  sarcoma.
The  patient  preferred  transcatheter  arterial  chemoem-
olization  (TACE)  to  surgical  resection.  Angiography
evealed  that  the  right  lobe  hepatic  mass  was  exclusively
upplied  by  the  right  IMA  rather  than  the  HA  in  the  ini-
ial  presentation  (Fig.  1d  and  e).  No  other  extrahepatic
ollateral  artery  was  identiﬁed.  TACE  was  performed  and
epeated  from  the  right  IMA  every  1—3  months.  During  each
ACE  session,  an  emulsion  of  5—10  mL  iodized  oil  (Fig.  1b),
0—60  mg  polyvinyl  alcohol  particles  and  20—40  mg  doxoru-
icin  were  delivered  until  stagnant  ﬂow  was  achieved.
The  patient  is  currently  doing  well  19  months  after  the
iagnosis,  and  has  undergone  seven  TACE  sessions  over
7  months.  Although  TACE  was  delivered  via  the  right  IMA
or  the  ﬁrst  ﬁve  TACE  sessions,  HA  supply  of  the  tumor  was
ppreciated  during  the  sixth  treatment  and,  therefore,  TACE
as  also  performed  on  this  vessel  for  the  sixth  and  seventh
essions  (Fig.  1f).
iscussion
s  an  extrahepatic  collateral  artery,  IMA  supply  2.2%  of
CC  patients  and  may  serve  as  a  feeding  artery  in  patients
ith  hepatic  artery  occlusion  caused  by  repeated  TACE
2,3].  Like  other  hepatic  tumors,  spindle  cell  sarcoma  can
cquire  its  vascular  supply  from  extrahepatic  collaterals  [4],
ncluding  the  IMA,  hence  emphasizing  the  importance  of
re-procedural  and  intra-procedural  imaging.  In  our  case,
re-procedural  CT  revealed  the  right  IMA  as  a  potential
eeder  of  the  tumor,  while  the  diagnosis  of  the  spindle  cell
arcoma  was  based  upon  the  classic  microscopic  ﬁndings
nd  immunohistochemical  results  [5].  Although  a  normal
atent  HA  was  revealed,  the  right  IMA  was  considered  as(a). Most of the oncocytic cells show positive expression of CD117
he  main  feeder  of  the  tumor  at  the  initial  TACE  session  of
he  patient.  Nevertheless,  predominant  involvement  of  the
A  was  later  detected  at  the  sixth  TACE  session  probably
ue  to  repeated  transarterial  embolization  of  the  IMA  in  the
resent  case.
There  is  no  standard  treatment  for  patients  with  pri-
ary  sarcomas  of  the  liver.  A  long-term  survival  is  possible
fter  complete  tumor  resection  in  a  preselected  popu-
ation  with  early-stage  disease  [6]. Locoregional  therapy
y  interventional  radiology  including  transarterial  infu-
ion  chemotherapy  is  also  effective  [7].  In the  current
ase,  repeated  TACE  via  the  IMA  was  technically  suc-
essful.  TACE  using  doxorubicin  was  clinically  tolerated
ith  a  positive  impact  on  disease  progression  of  the
atient  at  19  months.  Long-term  survival  may  be  possi-
le  in  this  patient  with  spindle  cell  sarcoma  treated  by
ACE  and  prompts  further  investigations  on  the  effec-
iveness  of  TACE  using  doxorubicin  in  these  rare  hepatic
umors.
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